Identifying genes for primary hypertension: Methodological limitations and gene-environment interactions

Journal of Human Hypertension

Volumn 23, Issue 4, 2009, Pages 227-237

  Franks, P W ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; ARGININE; BETA 2 ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN COUPLED RECEPTOR; GLYCINE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; METHIONINE; NITRIC OXIDE SYNTHASE; SALBUTAMOL; THREONINE; TROGLITAZONE;

AEROBIC EXERCISE; ARTERY RESISTANCE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; EXERCISE; GENE FUNCTION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; INTRON; KIDNEY PLASMA FLOW; LIFESTYLE MODIFICATION; PHYSICAL ACTIVITY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE;

ENVIRONMENT; GENETIC TECHNIQUES; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 63349092427     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.134     Document Type: Review

References (58)

1. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26 (1): 76-80.
2. van Dam RM, Hoebee B, Seidell JC, Schaap MM, de Bruin TW, Feskens EJ. Common variants in the ATPsensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: Population-based studies and meta-analyses. Diabet Med 2005; 22(5): 590-598.
3. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40(5): 638-645.
4. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008; 40(2): 189-197.
5. Sandhu MS, Waterworth DM, Debenham SL, Wheeler E, Papadakis K, Zhao JH et al. LDL-cholesterol concentrations: A genome-wide association study. Lancet 2008; 371(9611): 483-491.
6. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008; 40(2): 161-169.
7. The Wellcome Trust Case-Control Consortium. Genome- wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447(7145): 661-678.
8. Gu C, Borecki I, Gagnon J, Bouchard C, Leon AS, Skinner JS et al. Familial resemblance for resting blood pressure with particular reference to racial differences: Preliminary analyses from the HERITAGE Family Study. Hum Biol 1998; 70(1): 77-90.
9. Franks PW. Muscling in on the genetics of quantitative disease traits. J Appl Physiol 2007; 103(4): 1111-1112.
10. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993; 153(5): 598-615.
11. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 2007; 370 (9602): 1829-1839.
12. Ragland DR. Dichotomizing continuous outcome variables: Dependence of the magnitude of association and statistical power on the cutpoint. Epidemiology 1992; 3(5): 434-440.
13. Pickering TG, Harshfield GA, Kleinert HD, Blank S, Laragh JH. Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA 1982; 247 (7): 992-996.
14. Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. Lippincott-Raven, Inc.: Philadelphia, PA, 1998.
15. Last JM. A Dictionary of Epidemiology, 3rd edn. Oxford University Press: Oxford, 1995.
16. Slatkin M. Linkage disequilibrium - understanding the evolutionary past and mapping the medical future. Nat Rev Genet 2008; 9(6): 477-485.
17. Hopewell S, McDonald S, Clarke M, Egger M. Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst Rev 2007; (2): MR000010.
18. Lander ES. The new genomics: Global views of biology. Science 1996; 274(5287): 536-539.
19. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273(5281): 1516-1517.
20. Weedon MN, Lango H, Lindgren CM, Wallace C, Evans DM, Mangino M et al Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 2008; 40(5): 575-583.
21. Lettre G, Jackson AU, Gieger C, Schumacher FR, Berndt SI, Sanna S et al. Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet 2008; 40(5): 584-591.
22. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008; 40 (3): 281-283.
23. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008; 40(3): 316-321.
24. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008; 40(3): 310-315.
25. Franks PW, Knowler WC, Nair S, Koska J, Lee YH, Lindsay RS et al. Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians. Hypertension 2004; 44 (5): 681-688.
26. Lu Q, Elston RC. Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes. Am J Hum Genet 2008; 82(3): 641-651.
27. Beeks E, Kessels AG, Kroon AA, van der Klauw MM, de Leeuw PW. Genetic predisposition to salt-sensitivity: A systematic review. J Hypertens 2004; 22(7): 1243-1249.
28. Takashima Y, Kokaze A, Matsunaga N, Yoshida M, Sekiguchi K, Sekine Y et al. Relations of blood pressure to angiotensinogen gene T174M polymorphism and alcohol intake. J Physiol Anthropol Appl Human Sci 2003; 22(4): 187-194.
29. Gambier N, Marteau JB, Batt AM, Marie B, Thompson A, Siest G et al Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort. J Hypertens 2006; 24(11): 2199-2205.
30. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B et al. Beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999; 33(6): 1425-1430.
31. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, Skuppin J et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996; 14(2): 199-207.
32. Hagberg JM, McCole SD, Brown MD, Ferrell RE, Wilund KR, Huberty A et al. ACE insertion/deletion polymorphism and submaximal exercise hemodynamics in postmenopausal women. J Appl Physiol 2002; 92 (3): 1083-1088.
33. Jalil JE, Cordova S, Ocaranza M, Schumacher E, Braun S, Chamorro G et al. Angiotensin I-converting enzyme insertion/deletion polymorphism and adrenergic response to exercise in hypertensive patients. Med Sci Monit 2002; 8(8): CR566-CR571.
34. Kanazawa H, Okamoto T, Hirata K, Yoshikawa J. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162(4 Part 1): 1235-1238.
35. Krizanova O, Koska J, Vigas M, Kvetnansky R. Correlation of M235T DNA polymorphism with cardiovascular and endocrine responses during physical exercise in healthy subjects. Physiol Res 1998; 47(2): 81-88.
36. McCole SD, Brown MD, Moore GE, Ferrell RE, Wilund KR, Huberty A et al Angiotensinogen M235T polymorphism associates with exercise hemodynamics in postmenopausal women. Physiol Genomics 2002; 10 (2): 63-69.
37. Rankinen T, Gagnon J, Perusse L, Chagnon YC, Rice T, Leon AS et al AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study. Am J Physiol Heart Circ Physiol 2000; 279(1): H368-H374.
38. Roltsch MH, Brown MD, Hand BD, Kostek MC, Phares DA, Huberty A et al No association between ACE I/D polymorphism and cardiovascular hemodynamics during exercise in young women. Int J Sports Med 2005; 26(8): 638-644.
39. Zhang B, Sakai T, Miura S, Kiyonaga A, Tanaka H, Shindo M et al. Association of angiotensin-converting-enzyme gene polymorphism with the depressor response to mild exercise therapy in patients with mild to moderate essential hypertension. Clin Genet 2002; 62(4): 328-333.
40. Rauramaa R, Kuhanen R, Lakka TA, Vaisanen SB, Halonen P, Alen M et al. Physical exercise and blood pressure with reference to the angiotensinogen M235T polymorphism. Physiol Genomics 2002; 10 (2): 71-77.
41. Rudnick J, Puttmann B, Tesch PA, Alkner B, Schoser BG, Salanova M et al. Differential expression of nitric oxide synthases (NOS 1-3) in human skeletal muscle following exercise countermeasure during 12 weeks of bed rest. FASEB J 2004; 18(11): 1228-1230.
42. Balon TW, Nadler JL. Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol 1994; 77(6): 2519-2521.
43. Yang AL, Tsai SJ, Jiang MJ, Jen CJ, Chen HI. Chronic exercise increases both inducible and endothelial nitric oxide synthase gene expression in endothelial cells of rat aorta. J Biomed Sci 2002; 9(2): 149-155.
44. Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003; 107(25): 3152-3158.
45. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001; 104 (3): 342-345.
46. Vimaleswaran KS, Franks PW, Barroso I, Brage S, Ekelund U, Wareham NJ et al. Habitual energy expenditure modifies the association between NOS3 gene polymorphisms and blood pressure. Am J Hypertens 2008; 21(3): 297-302.
47. Kimura T, Yokoyama T, Matsumura Y, Yoshiike N, Date C, Muramatsu M et al. NOS3 genotype-dependent correlation between blood pressure and physical activity. Hypertension 2003; 41(2): 355-360.
48. Rankinen T, Rice T, Perusse L, Chagnon YC, Gagnon J, Leon AS et al NOS3 Glu298Asp genotype and blood pressure response to endurance training: The HERITAGE family study. Hypertension 2000; 36 (5): 885-889.
49. Franks PW, Ekelund U, Brage S, Wong MY, Wareham NJ. Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness? Diabetes Care 2004; 27 (5): 1187-1193.
50. Dengel DR, Brown MD, Ferrell RE, Reynolds TH, Supiano MA. A preliminary study on T-786C endothelial nitric oxide synthase gene and renal hemodynamic and blood pressure responses to dietary sodium. Physiol Res 2007; 56(4): 393-401.
51. Hoffmann IS, Tavares-Mordwinkin R, Castejon AM, Alfieri AB, Cubeddu LX. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 2005; 19(3): 233-240.
52. Florez JC, Jablonski KA, Kahn SE, Franks PW, Dabelea D, Hamman RF et al. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes 2007; 56(2): 531-536.
53. Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, Altshuler D et al. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 2007; 50(12): 2451-2460.
54. Bloche MG. Race-based therapeutics. N Engl J Med 2004; 351 (20): 2035-2037.
55. Temple R, Stockbridge NL. BiDil for heart failure in black patients: The US Food and Drug Administration perspective. Ann Intern Med 2007; 146(1): 57-62.
56. Franks PW, Bhattacharyya S, Luan J, Montague C, Brennand J, Challis B et al. Association between physical activity and blood pressure is modified by variants in the G-protein coupled receptor 10. Hypertension 2004; 43(2): 224-228.
57. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV et al. Lifestyle interventions to reduce raised blood pressure: A systematic review of randomized controlled trials. J Hypertens 2006; 24(2): 215-233.
58. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA et al Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116(9): 1081-1093.